Next Article in Journal
Favipiravir—Tautomeric and Complexation Properties in Solution
Next Article in Special Issue
Current Treatment Options in Homozygous Familial Hypercholesterolemia
Previous Article in Journal
Design, Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel Lapatinib Derivatives
Previous Article in Special Issue
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(1), 44; https://doi.org/10.3390/ph16010044
Action Date Notes Link
article xml file uploaded 28 December 2022 12:14 CET Original file -
article xml uploaded. 28 December 2022 12:14 CET Update https://www.mdpi.com/1424-8247/16/1/44/xml
article pdf uploaded. 28 December 2022 12:14 CET Version of Record https://www.mdpi.com/1424-8247/16/1/44/pdf
article supplementary file uploaded. 28 December 2022 12:14 CET - https://www.mdpi.com/1424-8247/16/1/44#supplementary
article html file updated 28 December 2022 12:15 CET Original file -
article html file updated 1 March 2023 06:34 CET Update -
article html file updated 5 March 2023 01:16 CET Update https://www.mdpi.com/1424-8247/16/1/44/html
Back to TopTop